about
Clinical Characteristics of Young Type 2 Diabetes Patients with AtherosclerosisAnalysis of the associations between vitamin D and albuminuria or β-cell function in Chinese type 2 diabetes.Comparisons of weight changes between sodium-glucose cotransporter 2 inhibitors treatment and glucagon-like peptide-1 analogs treatment in type 2 diabetes patients: A meta-analysis.Rs4074134 near BDNF gene is associated with type 2 diabetes mellitus in Chinese Han population independently of body mass index.Comparisons of the efficacy of alpha glucosidase inhibitors on type 2 diabetes patients between Asian and Caucasian.Age at diagnosis and C-peptide level are associated with diabetic retinopathy in Chinese.Baseline Body Mass Index and the Efficacy of Hypoglycemic Treatment in Type 2 Diabetes: A Meta-AnalysisEfficacy and safety of avandamet or uptitrated metformin treatment in patients with type 2 diabetes inadequately controlled with metformin alone: a multicenter, randomized, controlled trialThe Association of Retinopathy and Plasma Glucose and HbA1c: A Validation of Diabetes Diagnostic Criteria in a Chinese PopulationP38 plays an important role in glucolipotoxicity-induced apoptosis in INS-1 cells.The Magnitude of Weight Loss Induced by Metformin is Independently Associated with BMI at Baseline in Newly Diagnosed Type 2 Diabetes: Post-hoc Analysis from Data of a Phase IV Open-labeled Trial.Meta-analysis and critical review on the efficacy and safety of alpha glucosidase inhibitors in Asian and non-Asian populations.Genetic and Clinical Predictive Factors of Sulfonylurea Failure in Patients with Type 2 Diabetes.Decreased Glycemic Difference Between Diabetes and Nondiabetes in the Elderly Leads to the Reduced Diagnostic Accuracy of Hemoglobin A1c for Diabetes Screening in an Aged Chinese Population.Clinical and Genetic Features of Patients With Type 2 Diabetes and Renal Glycosuria.DPP-4 inhibitors and risk of infections: a meta-analysis of randomized controlled trials.Plasma NT-proBNP is independently associated with albuminuria in type 2 diabetes.Associated Factors with Biochemical Hypoglycemia during an Oral Glucose Tolerance Test in a Chinese Population.Relationship Between Gestational Weight Gain and Pregnancy Complications or Delivery Outcome.Efficacy of dipeptidyl-peptidase-4 inhibitors and impact on β-cell function in Asian and Caucasian type 2 diabetes mellitus patients: A meta-analysis.Search for genetic determinants of sulfonylurea efficacy in type 2 diabetic patients from China.A Novel Mutation of PRKAR1A Caused Carney Complex in a Chinese Patient.The Association Between the Dosage of SGLT2 Inhibitor and Weight Reduction in Type 2 Diabetes Patients: A Meta-Analysis.Addition of dipeptidyl peptidase-4 inhibitors to insulin treatment in type 2 diabetes patients: A meta-analysis.Brain derived neurotrophic factor in newly diagnosed diabetes and prediabetes.Combined Influence of Genetic Variants and Gene-gene Interaction on Sulfonylurea Efficacy in Type 2 Diabetic Patients.Comparisons of the efficacy of glucose control, lipid profile, and β-cell function between DPP-4 inhibitors and AGI treatment in type 2 diabetes patients: a meta-analysis.Serum leptin level is associated with glycaemic control in newly diagnosed type 2 diabetes patients: A 1-year cohort study.Efficacy of hypoglycemic treatment in type 2 diabetes stratified by age or diagnosed age: a meta-analysis.Comparison between insulin degludec/liraglutide treatment and insulin glargine/lixisenatide treatment in type 2 diabetes: a systematic review and meta-analysis.CDK1 switches mitotic arrest to apoptosis by phosphorylating Bcl-2/Bax family proteins during treatment with microtubule interfering agents.A Screening Approach for Mitochondrial tRNALeu(UUR) A3243G Mutation in a Hospital-Based Population with Diabetes.Lower Circulating miR-122 Level in Patients with HNF1A Variant-Induced Diabetes Compared with Type 2 DiabetesDPP-4 Inhibitor Treatment in Chinese Type 2 Diabetes Patients: A Meta-AnalysisEffect of Hemoglobin A1c Reduction or Weight Reduction on Blood Pressure in Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Treatment in Type 2 Diabetes Mellitus: A Meta-AnalysisDenosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: Systematic review and meta- analysisUrinary C-Peptide Creatinine Ratio as a Non-Invasive Tool for Identifying Latent Autoimmune Diabetes in Adults (LADA)Characteristics of Newly Diagnosed Type 2 Diabetes in Chinese Older Adults: A National Prospective Cohort StudyClinical Implications of Urinary C-Peptide Creatinine Ratio in Patients with Different Types of DiabetesBaseline Triglyceride Level Affected the Efficacy of Vildagliptin in Treating Type 2 Diabetes: A Post Hoc Analysis of the VISION Study
P50
Q28552472-511DE44C-3F16-4058-B37D-67EAEF141CB6Q33598036-4D468FEC-A57A-4F92-A1D4-F79318686BD2Q33871397-B057397B-3ED2-4410-9C52-5E0510C27EBBQ34595193-A087C211-5BD0-4A2C-942E-B841AAF8DE62Q35043812-028A60B9-DD20-46C5-8818-152C42914290Q35116153-5335261C-85A6-47D1-8F09-83FD7A862889Q36217673-6F381903-ACF8-4421-A633-7D6853B1643FQ36794427-53A8CA28-47D9-4115-A8A8-3209EB5BA236Q37363663-B82F7E01-D40F-46A3-B45D-13A096CADCCCQ38482120-D7A4D1B1-88C4-4DDA-B461-E9710A253BD7Q38686963-6E8C3FD9-A303-4D80-A1C5-E90BF34460BBQ39420555-A8439311-F0E5-4FD9-A0DB-A12AA199182FQ39610528-E7B193C7-92D4-4F0A-9B61-57E138A0471DQ39984516-A484A695-A69F-4A23-A977-6D2C93C9F574Q40282593-46E2E4AD-71AA-4FED-803B-A1EE3E03B64CQ40487459-3FA4BDF6-D58B-410A-8EE6-2FF2A064DB1BQ40883436-F5EB2AF1-EBCD-4835-BD58-449F94A7704AQ41622999-CCCC73B2-102B-416A-9603-3085A84BA9CBQ42286120-248CE7D8-3AE9-453E-8991-F474F313742CQ43462577-EFA50A1D-1409-4059-86F5-A0B27624B5CFQ45869049-7920CD52-F416-4CF6-845F-2EAD36B40550Q47157370-D958B116-C7B9-4AF3-B400-2F9B50AE108AQ47175811-AD2CAF7E-E790-4D89-AC10-8714A4942E62Q47764756-FEAFA2F7-99CC-479C-9417-FF1D66A36BD1Q50910637-3AC662D4-08E7-448A-B672-CC3D09B929DFQ51286875-E5663CC9-A1AE-42B2-BEEA-BA4F1967D704Q51301791-5F5A1553-B432-4DAF-9326-7DAE4C29AE96Q51684256-812CAD06-6CD8-4C6D-B307-61A1BE00D539Q51693237-A70DAC86-10A2-4BCF-B93F-98D8B0D5EEFAQ51769082-F8E472D1-1F6E-4F03-993D-3A23FB57EAB5Q53060280-4D044F49-CB38-4DCD-8848-EB669624EF79Q55016952-C16D2954-A5CB-4BA6-83B3-2A69615E57F1Q58805816-47D18B0D-7C74-42CB-8EDA-EAE5A540D2C9Q88905311-188E2512-F489-482C-AFDE-5C82988B2C77Q90726814-35DAAD1A-3836-4639-811E-4BBA032C47F6Q91070840-51401E65-548A-4967-9A49-31CB6D4B30EDQ91829605-748CEA7D-64A1-43C5-9DE8-74A2EF89A628Q91900845-EDA3D45F-95B9-4BB6-B738-E1D36CB518A0Q93110072-7372E8F2-EC5C-4CB6-91C1-FD02E63BF8CAQ93110141-4646437D-36FB-4C16-9E0B-FB56C02BF134
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Xiaoling Cai
@ast
Xiaoling Cai
@en
Xiaoling Cai
@es
Xiaoling Cai
@nl
type
label
Xiaoling Cai
@ast
Xiaoling Cai
@en
Xiaoling Cai
@es
Xiaoling Cai
@nl
prefLabel
Xiaoling Cai
@ast
Xiaoling Cai
@en
Xiaoling Cai
@es
Xiaoling Cai
@nl
P106
P1153
7401848361
P31
P496
0000-0002-7881-0543